These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 354037)

  • 1. Another look at erythromycin.
    Straughan JL
    S Afr Med J; 1978 Apr; 53(14):527-30. PubMed ID: 354037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new look at erythromycin.
    Lacey RW
    Postgrad Med J; 1977 Apr; 53(618):195-200. PubMed ID: 323837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug therapy reviews: antimicrobial spectrum, pharmacology and therapeutic use of erythromycin and its derivatives.
    Meade RH
    Am J Hosp Pharm; 1979 Sep; 36(9):1185-9. PubMed ID: 386785
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythromycin--three decades later.
    Straughan JL; Anderson R
    S Afr Med J; 1983 Aug; 64(6):197-201. PubMed ID: 6348968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute bacterial infections of the upper respiratory tract.
    Nadkarni MS; Shah PA; Thakurdesai S
    Curr Med Res Opin; 1977; 4(8):544-54. PubMed ID: 326492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multicenter study of the clinical efficacy and tolerance of roxithromycin compared to erythromycin ethylsuccinate in lower respiratory tract infections].
    Bertrand A; Jonquet O; Sauvaget J
    Pathol Biol (Paris); 1988 May; 36(5):544-7. PubMed ID: 3043354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The erythromycins.
    Pumphrey RE
    Ear Nose Throat J; 1981 May; 60(5):222-3. PubMed ID: 7227269
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibiotic resistance: relationship to persistence of group A streptococci in the upper respiratory tract.
    Gerber MA
    Pediatrics; 1996 Jun; 97(6 Pt 2):971-5. PubMed ID: 8637784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of an oral erythromycin product.
    Fraser DG
    Am J Hosp Pharm; 1980 Sep; 37(9):1199-205. PubMed ID: 6998290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous erythromycin in acute chest infections in critically ill patients.
    Cade JF; Pain MC
    Anaesth Intensive Care; 1979 May; 7(2):143-7. PubMed ID: 507348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intravenous erythromycin lactobionate in respiratory infections.
    Di Sciacca A; Durante F; Cucchiara G; Ingrassia A; Mira G; Mannone F; Di Piazza RM; Frontini A; Barbagallo Sangiorgi G
    J Int Med Res; 1987; 15(4):245-50. PubMed ID: 3653502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythromycin estolate in general practice. A comparative trial of two dosage forms.
    Grainger GJ
    Practitioner; 1969 Jul; 202(213):84-6. PubMed ID: 4895696
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experiences with erythromycin in infant infections, especially respiratory tract infections].
    Sander C
    Klin Padiatr; 1972 Jan; 184(1):55-8. PubMed ID: 4402000
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical observations with clarithromycin in pediatrics].
    Sekiguchi T; Okamoto T; Ohara K; Nishimori M; Kozan S; Miyazaki M
    Jpn J Antibiot; 1989 Feb; 42(2):411-9. PubMed ID: 2526254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Personal experience with erythromycin in the treatment of respiratory tract infections].
    Willeit A; Erckert W; Prunner K
    Minerva Pediatr; 1976 Sep; 28(30):1855-61. PubMed ID: 1012219
    [No Abstract]   [Full Text] [Related]  

  • 16. [Erythromycin in the modern antibiotic therapy of bacterial infections (a review lecture)].
    Kuznetsova SM
    Antibiotiki; 1982 May; 27(5):365-72. PubMed ID: 7103441
    [No Abstract]   [Full Text] [Related]  

  • 17. The erythromycins. A further report from the Australian Drug Evaluation Committee.
    Med J Aust; 1973 Jul; 2(4):192-3. PubMed ID: 4741351
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical evaluation of a new antibacterial agent, xibornol, in the treatment of bacterial infections of the upper respiratory tract in childhood. Comparison with erythromycin].
    Capristo AF; Maiello N; Coppola T; Decimo F; Miraglia del Giudice M; Antignani RG
    Minerva Pediatr; 1986 Jun; 38(11-12):503-10. PubMed ID: 3526110
    [No Abstract]   [Full Text] [Related]  

  • 19. Telithromycin: new preparation. A needless addition to the other macrolides.
    Prescrire Int; 2003 Feb; 12(63):8-11. PubMed ID: 12602373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration of erythromycin in respiratory tract infections.
    Walstad RA; Hellum KB
    Acta Otolaryngol Suppl; 1984; 407():50-4. PubMed ID: 6333775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.